Microsoft word - r0986867

SAFETY DATA SHEET
according to Regulation (EU) No. 1907/2006 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING
: Tetracycline hydrochloride
The Old Brickyard NEW ROAD, GILLINGHAM Dorset SP8 4XT UNITED KINGDOM 2. HAZARDS IDENTIFICATION
Risk advice to man and the environment
Irritating to eyes, respiratory system and skin.
3. COMPOSITION/INFORMATION ON INGREDIENTS
Tetracycline hydrochloride
64-75-5 200-593-8
4. FIRST AID MEASURES
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing give artificial respiration Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Sigma - T7660 www.sigma-aldrich.com
5. FIRE-FIGHTING MEASURES
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special protective equipment for fire-fighters
Wear self contained breathing apparatus for fire fighting if necessary.
6. ACCIDENTAL RELEASE MEASURES
Personal precautions
Use personal protective equipment. Avoid dust formation. Avoid breathing dust. Ensure adequate ventilation.
Environmental precautions
Do not let product enter drains.
Methods for cleaning up
Pick up and arrange disposal without creating dust. Keep in suitable, closed containers for disposal.
7. HANDLING AND STORAGE
Handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed. Normal measures for preventive fire
protection.
Storage
Store in cool place.Keep container tightly closed in a dry and well-ventilated place.
8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Contains no substances with occupational exposure limit values. Personal protective equipment
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a dust mask type N95 (US) or
type P1 (EN 143) respirator. Use respirators and components tested and approved under appropriate
government standards such as NIOSH (US) or CEN (EU).
Hand protection
Handle with gloves. The selected protective gloves have to satisfy the specifications of EU Directive
89/689/EEC and the standard EN 374 derived from it.
Eye protection
Safety glasses
Skin and body protection
Choose body protection according to the amount and concentration of the dangerous substance at the work
place.
Hygiene measures
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at
the end of workday.
9. PHYSICAL AND CHEMICAL PROPERTIES
Appearance
Safety data
Sigma - T7660 www.sigma-aldrich.com
10. STABILITY AND REACTIVITY
Storage stability
Stable under recommended storage conditions. May discolor on exposure to light.
Materials to avoid
Strong oxidizing agents
Hazardous decomposition products
Hazardous decomposition products formed under fire conditions.
Carbon oxides, nitrogen oxides (NOx), Hydrogen chloride gas
11. TOXICOLOGICAL INFORMATION
Acute toxicity
Irritation and corrosion
Sensitisation
Prolonged or repeated exposure may cause allergic reactions in certain sensitive individuals. Chronic exposure
This product is or contains a component that is probably not carcinogenic based on its IARC, ACGIH, NTP, or EPA classification. Signs and Symptoms of Exposure
phototoxic reactions, Gastrointestinal disturbance, yellowing of teeth, reduced mineralization Potential Health Effects
Inhalation
May be harmful if inhaled. Causes respiratory tract irritation. May be harmful if absorbed through skin. Causes skin irritation. Ingestion
Target Organs
12. ECOLOGICAL INFORMATION
Elimination information (persistence and degradability)
Ecotoxicity effects
LC50 - Salvelinus namaycush - 220 mg/l - 96 h Sigma - T7660 www.sigma-aldrich.com
Further information on ecology
13. DISPOSAL CONSIDERATIONS
Product
Observe all federal, state, and local environmental regulations.Contact a licensed professional waste disposal
service to dispose of this material. Dissolve or mix the material with a combustible solvent and burn in a
chemical incinerator equipped with an afterburner and scrubber.

Contaminated packaging
Dispose of as unused product.
14. TRANSPORT INFORMATION
ADR/RID
Not dangerous goods
IMDG
Not dangerous goods
IATA
Not dangerous goods
15. REGULATORY INFORMATION
Labelling according to EC Directives
Irritating to eyes, respiratory system and skin. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. 16. OTHER INFORMATION
Further information
Copyright 2007 Sigma-Aldrich Co. License granted to make unlimited paper copies for internal use only.
The above information is believed to be correct but does not purport to be all inclusive and shall be used
only as a guide. The information in this document is based on the present state of our knowledge and is
applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee
of the properties of the product. Sigma-Aldrich Co., shall not be held liable for any damage resulting from
handling or from contact with the above product. See reverse side of invoice or packing slip for additional
terms and conditions of sale.
Sigma - T7660 www.sigma-aldrich.com

Source: http://radio.cuci.udg.mx/bch/EN/Sicherheit/SDB/Tetracycline-HCl_Sigma.pdf

News18 - revise 1.pdf

Published by The Raynaud’s Association, Inc. © Raynaud’s Association 2004 Raynaud’s persons said to have primary Raynaud’s New Medical Phenomenon & turally normal but seem to have a height- Advisory Board ened response to environmental stress. In Digital Ulcers this “haystack” of a very common com-plaint lies the “needle” of secondary Ray- By Lynn Wund

Medicines issued in hospital in 2009

FACTSHEET NHS Drug Expenditure – Top 10 When the NHS was launched in 1948 it had a budget of £437million (roughly £9billion at today’s value). In 2008/9 it received over 10 times that amount (more than £100billion). This equates to an average rise in spending over the full 60-year period of about 4% a year once inflation has been taken into account. However, in recent years investm

Copyright © 2010 Find Medical Article